Identifying fusion genes from paired-end ribonucleic acid (rna) sequencing (rna-seq) data has the advantage that only expressed fusion genes will be found.
MediSapiens develops web-based software solutions to its customers in various pharmaceutical, healthcare, and life science sectors.
The company’s Explorer™ technology platform is a collection of modules and functionalities in database, data processing, and analytics. These industry-tested components enable MediSapiens to rapidly and cost-effecively deliver customised software.
MediSapiens offers genomic, biomedical, and clinical bio-IT solutions, as well as digitisation of bio-businesses, and scientific and data services.
Custom software for bio-businesses and biomedical researchers
MediSapiens offers software solutions based on existing modules and functionalities, resulting in quick, cost-effective, and customised development.
The company also works closely with its customers to ensure a personalised solution, from initial ideas to delivery and maintenance. MediSapiens’ experts in biology, genetics, bioinformatics, and software development helps clients determine a solution, which fully meets their needs and expectations.
Genomic, biomedical, and clinical bio-IT solutions
MediSapiens has integrated massive datasets of genomic, biomedical, and clinical data into a single system, allowing management and import with fast storage and browsing. The interactive web-based user interfaces enable researchers to easily find and interpret data.
The systems have access to curated reference databases, such as fully curated The Cancer Genome Atlas (TCGA) data, which can be quickly and efficiently analysed through intelligent filters, analysis tools, and visualisation options. Data can be flexibly shared with both internal and external users and groups.
Powerful visualisation tools, such as scatter plots, bar charts, gene and target area visualisations, and survival plots enable effective data research via intuitive graphical interfaces.
Permission to all data is guided by powerful access control systems, which ensure correct management of confidential and sensitive data.
MediSapiens can host solutions in its Tier 3 secure server halls and commercial clouds. The company can also maintain customer-hosted solutions.
Digitisation of bio-business
MediSapiens’ integrated Bio-IT solutions help bio-businesses improve connectivity, collaboration, and result delivery. Medisapiens has expertise in digitisation, helping bio-busines customers to improve internal processes and customer experience.
The company develops solutions to replace laboratory systems, emails, spreadsheets, analysis systems, and PDF reports, with result delivery portals and integrated, convenient, web-based data management and analysis solutions. Medisapiens helps digitising processes, products, and services from customer orders to analysis and reporting.
An example of bio-business digitisation is the consumer-oriented dog genetic testing service MyDogDNA. Developer and marketer Genoscoper Laboratories decided to partner with MediSapiens to develop a full Bio-IT infrastructure and solution. Medisapiens created an integrated system, so a visitor of the site can order test kits then access a customer portal presenting interpreted genetic test results. This system also enables data sharing and finds matches for breeding purposes.
Scientific and data analysis services
MediSapiens’ team comprises several biomedical scientists and has worked with numerous scientific and data projects both in the pharmaceutical industry and in academic research.
Medisapiens shows expertise with multiple types of clinical, phenotypic, genomic, diagnostic, and transcriptomic data, and helps customers in demanding data curation and data analysis projects.
For data analytics, IST Online, FusionSCOUT gene fusion detection pipeline, and TargetSCOUT visual snapshots are available, or MediSapiens can develop custom genetic analyses for proprietary and public data. The customised service can also cater to large datasets requiring powerful computational resources.
MediSapiens is a company that works with genomic data management, analysis, and visualisation. Clinical, biomedical, and genomic data is increasing at a stunning pace, which is both a challenge and an opportunity for life science researchers and bio-business industry. MediSapiens interprets this data and helps turn it into new discoveries, innovations, and business through digitisation.
Innatoss Laboratories and MediSapiens have partnered to develop a novel Lyme borreliosis (LB) diagnostic interpretation and communication solution.
MediSapiens has collaborated with The Pistoia Alliance, a global, non-profit alliance of life science companies, vendors, publishers and academic groups.
MediSapiens has announced it will be attending the International Society and the International Foundation for Animal Genetics (ISAG) event this week.
MediSapiens has extended its delivery network solutions for management and analysis of genomic and clinical data through in Microsoft's Azure Cloud.
MediSapiens has joined a study that compared human genomes to those of dogs, which could lead to revolutionary disease treatments.
Developer and provider of genomic and healthcare data solutions MediSapiens has announced it will extend its solution delivery network by offering its Explorer™ Platform based solutions in Microsoft's Azure Cloud.
MediSapiens has announced it is taking part in a newly established genomic research project, which focuses on comparing dog and human genomes to advance human health.
MediSapiens has been listed on 20 Most Promising Biotech Technology Solution Providers list by CIOReview.
Finnish developer and provider of bio-IT solutions for research and biomedicine MediSapiens is a partner of an international consortium aiming to develop personalised medicine applications using integrated genome and other health data.
Bio-IT solution provider MediSapiens has won Red Herring Top 100 Europe award, announced at the Top 100 forum in Amsterdam.